Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluate the Immunogenicity of a Novel Glucagon Formulation

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Locemia Solutions ULC
ClinicalTrials.gov Identifier:
NCT01959334
First received: October 5, 2013
Last updated: November 19, 2014
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)